Company / Working Capital
Beam Therapeutics Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.2B
FY2025
5-year range
$696.1M / $1.2B
FY2021-FY2025
Trend
+68.3%
vs FY2024
Sector context
#36 of 213
Health Care
What the data says
Beam Therapeutics Inc.'s working capital of $1.2B is higher than 83% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 7 years, ranging from $65M in FY2019 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +41.6%. Top quartile in the Health Care sector.
Improved from $1.0B to $1.2B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +10.5%
- 5-Year CAGR
- +41.6%
- 10-Year CAGR
- -
Sector benchmark
+25.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +41.6%, indicating consistent growth.
- In FY2025, working capital increased 68.3% year-over-year.
- Ranks #36 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +68.3% |
| FY2024 | $696.1M | -30.8% |
| FY2023 | $1.0B | +15.7% |
| FY2022 | $869.3M | -18.0% |
| FY2021 | $1.1B | +414.4% |
| FY2020 | $206.0M | +214.9% |
| FY2019 | $65.4M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026